Biotechnology Stocks I Performance Guide: Intellia Therapeutics, Inc. (NTLA)
NTLA has no dividends.
Table and Chart of NTLA Performance
See what a $1,000 investment in NTLA is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| NTLA Returns | |
|---|---|
| Start Date | Jun-30-2016 |
| Start Price | $21.35 |
| End Date | Jul-26-2024 |
| End Price | $26.50 |
| # Prices | 98 |
| Min Date | May-31-2017 |
| Min Price | $11.46 |
| Max Date | Jun-30-2021 |
| Max Price | $161.91 |
| Total Return | 24.12% |
| Annualized Return | 2.68% |
| Current Value of $1,000 Purchase | $1,241 |
| Number Returns | 4,753 |
| Average Return | 124.07% |
| Number Profitable Returns | 3,137 |
| Percent Profitable Returns | 66.00% |
| Number Unprofitable Returns | 1,616 |
| Percent Unprofitable Returns | 34.00% |
| Profitable to Unprofitable Returns Ratio | 1.94 |
| NTLA Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $2,573,964,000 |
| Beta | 1.812 | Price to Sales | 64.30 |
| Earnings per Share | $-5.3700 |
| PE Ratio | None |
| PE to Growth Ratio | -0.0969 |
| Price to Book | 2.223 |
| PRICE DATA | |
| 52 Week High | $43.06 |
| 52 Week Low | $19.37 |
| Analyst Target Price | $69.61 |
| 50-Day Moving Average | $24.39 |
| 200-Day Moving Average | $26.51 |
| FINANCIAL DATA | |
| Revenue per Share | $0.58 |
| Revenue | $52,604,000 |
| Profit Margin | 0% |
| Return on Equity | -43.6% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
NTLA Compare Returns with S&P 500
NTLA Trendline Chart
NTLA Moving Average Chart
NTLA Stock Return Map - See Patterns of Gains and Losses
NTLA Stock Returns/Purchase Dates